In addition, the Company's Vice President of Clinical Development, Barbara Mittleman, M.D, is an invited speaker at the congress in the following Scientific Session: AbelZeta is a global ...
Lupus, or systemic lupus erythematosus (SLE), is a chronic, multisystem, autoimmune disorder with a heterogeneity of presentation so remarkable that is has also been termed “the disease with a ...
The oral presentation, entitled “IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, inhibits disease development in lupus-prone NZBW/F1 mice,” will be made during the session “Therapeutic Strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback